Arena Pharmaceuticals Inc (ARNA.A)

ARNA.A on American Stock Exchange

3.97USD
1:04pm EDT
Change (% chg)

$-0.04 (-1.00%)
Prev Close
$4.01
Open
$3.96
Day's High
$4.01
Day's Low
$3.90
Volume
10,937
Avg. Vol
12,324
52-wk High
$6.57
52-wk Low
$3.26

ARNA.A

Chart for ARNA.A

About

Arena Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. The Company’s drug, BELVIQ (lorcaserin HCl), was approved by the United States Food and Drug Administration for chronic weight management in adults. The Company also has... (more)

Overall

Beta: -0.71
Market Cap(Mil.): $970.58
Shares Outstanding(Mil.): 242.04
Dividend: --
Yield (%): --

Financials

  ARNA.A Industry Sector
P/E (TTM): -- 303.02 38.01
EPS (TTM): -0.26 -- --
ROI: -20.23 -5.79 15.44
ROE: -46.71 -6.75 16.48
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Pechala's Reports
$1,000.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks